News and Press Releases
Valo Therapeutics Recruits Charlotta Backman as VP Clinical Operations and Regulatory Affairs
Charlotta Backman (M. Sc) has a strong background in clinical research, with over 15 years of experience in start-up, conduct and close-out of Phase I to Phase IV clinical trials, including trials in oncology and vaccines, but also in hypertension and dermatology. Charlotta joined Valo Therapeutics in March 2017, to oversee and lead all clinical operations and regulatory affairs. Over the years, Charlotta has also gained experience from interactions with several regulatory authorities in the EU and in the US,
Valo Therapeutics recruits Antti Vuolanto as COO
Antti Vuolanto has recently joined Valo Therapeutics to fulfill the position of COO, bringing over 10 years of biotechnology and operational management experience to the company.